Agent Orange exposure linked to life-threatening prostate cancer
A new analysis has found a link between exposure to Agent Orange and lethal forms of prostate cancer among US Veterans. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that Agent Orange exposure history should be incorporated into prostate screening decisions for Veterans.
The herbicide Agent Orange was heavily used during the Vietnam War era and was often contaminated with dioxin, a dangerous toxin and potential carcinogen. Prior research suggests that exposure to Agent Orange may increase men’s risk of developing prostate cancer, but it is unclear whether it specifically increases their risk of developing lethal forms of the disease. “This is an important distinction as the majority of prostate cancer cases are non-lethal and thus do not necessarily require detection or therapy. Having a means of specifically detecting life-threatening cancer would improve the effectiveness of screening and treatment of prostate cancer,” said Mark Garzotto, MD, of the Portland Veterans Administration Medical Center and Oregon Health & Science University.
To look for a link between Agent Orange exposure and life-threatening, or high-grade, prostate cancer, Nathan Ansbaugh, MPH, designed and conducted analyses on a group of 2,720 US Veterans who were referred by multiple providers for initial prostate biopsy. Biopsy results and clinical information were compiled for analysis by principal investigator Dr. Garzotto.
Prostate cancer was diagnosed in 896 (32.9 percent) of the Veterans; 459 (16.9 percent) had high-grade disease.
Agent Orange exposure was linked with a 52 percent increase in overall risk of prostate cancer detection by biopsy. Exposure to the herbicide did not confer an increase in risk of low-grade prostate cancer, but it was linked with a 75 percent increase in risk of high-grade prostate cancer. In addition, Agent Orange exposure was associated with more than a two-fold increase in the highest-grade, most lethal cancers.
This study indicates that determining men’s Agent Orange exposure status is a readily identifiable means of improving prostate cancer screening for US Veterans, allowing for earlier detection and treatment of lethal cases and potentially prolonging survival and improving quality of life. “It also should raise awareness about potential harms of chemical contaminants in biologic agents used in warfare and the risks associated with waste handling and other chemical processes that generate dioxin or dioxin-related compounds,” said Dr. Garzotto.
Prostate-specific antigen (PSA) level is typically used as a dichotomous test for prostate cancer, resulting in overdiagnosis for a substantial number of men. The rate at which serum PSA levels change (PSA velocity) may be an important indicator of the presence of life-threatening disease.
Prostate cancer is an uncontrolled (malignant) growth of cells in the prostate gland (a male sex gland). The prostate gland is located at the base of the bladder and produces fluids that form part of semen to protect sperm. The prostate gland surrounds the passage (urethra) through which urine from the bladder exits the penis. The normal prostate gland is the size of a walnut in a young man and enlarges with age.
Prostate cancer, unlike many other forms of cancer, tends to be slow growing. Eventually it can spread to other organs and tissues, including bones.
How do you get Prostate Cancer?
Prostate cancer is the most commonly diagnosed cancer in men. It develops from cells within the gland. Risk factors include age; 75% of cases are in men over 65 years. There are more cases in western countries and 10% of cases can be linked to a person’s family history. Dietary and other factors in the environment are also linked to prostate cancer.
The exact cause of prostate cancer, like many cancers, is not known.
Doctors know, however, that the growth of the cancer is dependent on the male sex hormone testosterone.
A hormone is a chemical signal that is released by various glands in the body, carried in the blood, and which then controls the function of other organs, for example, their growth.
Hormones can also control the growth of cancer cells as well and this is what testosterone does in prostate cancer.